-
Racial Disparities and the Impact of Access Restrictions to Apixaban in Part D
Mar 10, 2025, 14:00 PM -
Pharmacovigilance Studies Using a Representative Sample From the French National Health Insurance Database (ESND): A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Assessment of Cytomegalovirus Status and Risk Stratification in Renal Transplant Recipients in Mexico: A Real-World Study
Mar 10, 2025, 14:00 PM -
Real-Word Data on Long-Term Outcomes Among Adult Patients With Myopericarditis Related Heart Failure
Mar 10, 2025, 14:00 PM -
Expediting Evidence Synthesis: A Review of Recent Research Evaluating Artificial Intelligence's Performance in Evidence Synthesis and Summarization of Clinical Literature
Mar 10, 2025, 14:00 PM -
What's Cost Got To Do With It? A Review of Key Issues Related to Costs in Health Technology Assessments in Non-Small-Cell Lung Cancer
Mar 10, 2025, 14:00 PM -
Mapping Disparities in Clinical Trial Enrollment Among HCC Patients: Insights From Social Determinants of Health
Mar 10, 2025, 14:00 PM -
Cost-Efficiency Modeling of Conversion to Biosimilar Rituximab-pvvr in Diffuse Large B-Cell Lymphoma in Medicare
Mar 10, 2025, 14:00 PM -
Number Needed to Treat and Associated Costs Per Additional Responder of Biologic Therapies in Adult Patients With Moderate To Severe Atopic Dermatitis
Mar 10, 2025, 14:00 PM -
Mind The Gap: Delays Between Vaccine Licensure And NITAG Recommendation In The US Versus Europe
Mar 10, 2025, 14:00 PM -
Healthcare Resource Optimization of Different Formulations: Daratumumab SC Compared To Daratumumab IV for Treating Multiple Myeloma
Mar 10, 2025, 14:00 PM -
Costs Avoided by the Inclusion of Finerenone Based on Hospitalization and Death Due to Cardiovascular Events and the Progression of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Colombia
Mar 10, 2025, 14:00 PM -
Cognitive Impairment Detection through Recurrent Neural Networks and Mobile Health Technologies
Mar 10, 2025, 14:00 PM -
Radiofrequency Renal Denervation for Uncontrolled Hypertension: A Cost-Effectiveness Analysis Based on the SPYRAL HTN-ON MED Trial for the Colombian Healthcare System
Mar 10, 2025, 14:00 PM -
Analysis of Public Expenditure of Pharmaceutical Utilization of Female Infertility in Hungary in the Last Decade
Mar 10, 2025, 14:00 PM -
Cancer Survivors and Opioid Use During Survivorship - A Scoping Review
Mar 10, 2025, 14:00 PM -
Are Existing Descriptions of Unmet Medical Need Fit for Purpose in the CMS Drug Negotiation Program Context?
Mar 10, 2025, 14:00 PM -
Examining Health Behaviour of Inviduals Diagnosed With Polycystic Ovary Syndrome
Mar 10, 2025, 14:00 PM -
Payer Perspectives on ICER Evidence Reports: InsightsInto Utility for Coverage and Formulary Decision-Making
Mar 10, 2025, 14:00 PM -
National Assessment of Depression Between Early vs Late Adolescents Using National Survey of Child Health Survey
Mar 10, 2025, 14:00 PM
